The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Neuropathology of prion diseases
Abstract
In prion diseases, neuropathology has remained the most important tool to give a definite diagnosis, and neuropathological research has contributed significantly to our current pathogenetic understanding. Immunohistochemistry for the disease-associated prion protein (PrP(Sc)) is indispensable for the neuropathological confirmation of prion diseases. The amount and distribution of PrP(Sc) deposits do not always correlate with type and severity of local tissue damage. PrP(Sc) deposition occurs only where neuronal parenchyma is present; in scarred infarctions with prominent gliosis, PrP(Sc) does not accumulate. Early, severe and selective loss affects a subset of inhibitory GABAergic neurons both in human and experimental prion diseases. The central pathogenetic cascade includes oxidative stress to neurons and their apoptosis. New patterns of PrP(Sc) immunoreactivity include granular ganglionic and tiny adaxonal PrP(Sc) deposits in peripheral nervous tissue, and dendritic cells and macrophages in vessel walls, suggesting that mobile haematogenous cells may be involved in spread of prions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the deposition patterns of misfolded PrPSc are diverse in murine models of prion disease, the heterogeneity of PrPSc deposition patterns is higher in human prion diseases and comprises synaptic, perivacuolar, plaque-like, kuru-plaque, florid-plaque, punctuate, perineuronal, and intraneuronal patterns, which might occur side-by-side or even overlapping in the same patient [119,120].”
From Loss of Homeostatic Microglia Signature in Prion Diseases (2022) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Normal host prion protein necessary for scrapie-induced neurotoxicity
Brandner, S., Isenmann, S., Raeber, A. J., Fischer, M., Sailer, A. W., Kobayashi, Y., Marino, S., Weissmann, C., & Aguzzi, A. (1996) · Nature · doi:10.1038/379339a0 · Cited by 813
Brown, P., Gibbs, C. J., Rodgers‐Johnson, P., Asher, D. M., Sulima, M. P., Bacote, A. E., Goldfarb, L. G., & Gajdusek, D. C. (1994) · Annals of Neurology · doi:10.1002/ana.410350504 · Cited by 813
Hill, A. F., Butterworth, R. J., Joiner, S., Jackson, G. S., Rossor, M. N., Thomas, D. J., Frosh, A. C., Tolley, N., Bell, J. E., Spencer, M. D., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12075-5 · Cited by 698
Prions prevent neuronal cell-line death
Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Matsumoto, Y., Yokoyama, T., Itohara, S., et al. (1999) · Nature · doi:10.1038/22241 · Cited by 443
Budka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K. A., et al. (1995) · Brain Pathology · doi:10.1111/j.1750-3639.1995.tb00625.x · Cited by 428
Self-citationScrapie prion proteins are synthesized in neurons.
Kretzschmar, H. A., Prusiner, S. B., Stowring, L., & DeArmond, S. J. (1986) · PubMed Central · Cited by 423
Molecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 365
Self-citationMolecular Cloning of a Human Prion Protein cDNA
Kretzschmar, H. A., Stowring, L., Westaway, D. A., Stubblebine, W. H., Prusiner, S. B., & DeArmond, S. J. (1986) · DNA · doi:10.1089/dna.1986.5.315 · Cited by 342
Developmental expression of the prion protein gene in glial cells
Moser, M., Colello, R. J., Pott, U., & Oesch, B. (1995) · Neuron · doi:10.1016/0896-6273(95)90307-0 · Cited by 321
Research works printed but not linked: 2
- Ribadeau-Dumas JL, Escourolle R. The Creutzfeldt-Jakob syndrome: a neuropathological and electron microscopic study. In: Subirana A, Espalader JM. (eds) Neurology. Amsterdam: Elsevier, 1974; 316–29
- Hainfellner JA, Budka H. Immunomorphology of human prion diseases. In: Court L, Dodet B. (eds) Transmissible Spongiform Encephalopathies: Prion Diseases. Paris: Elsevier, 1996; 75–80
Cited by
Sorted by citations
Role of Microglia in Central Nervous System Infections
Rock, R. B., Gekker, G., Hu, S., Sheng, W. S., Cheeran, M., Lokensgard, J. R., & Peterson, P. K. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.942-964.2004 · Cited by 723
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 390
Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
Ferreira, S. T., Vieira, M. N. N., & De Felice, F. G. (2007) · IUBMB Life · doi:10.1080/15216540701283882 · Cited by 335
A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain
Peretz, D., Williamson, R. A., Legname, G., Matsunaga, Y., Vergara, J., Burton, D. R., DeArmond, S. J., Prusiner, S. B., & Scott, M. R. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00726-2 · Cited by 224
González, L., Мартин, С., Begara‐McGorum, I., Hunter, N., Houston, F. E., Simmons, M. M., & Jeffrey, M. (2002) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0516 · Cited by 203
Metadata
- Authors
- Budka, H.
- Affiliations
- University of Vienna (AT)
- Corresponding author
- Budka, Herbert
- ORCID
- Budka, Herbert
- Venue
- British Medical Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 66
- Issue
- 1
- Pages
- 121-130
- ISSN
- 0007-1420 (ISSN-L)
- 1471-8391
- OpenAlex
- W2150554290
- Cited by
- 196
- References
- 56
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 1 · 2023: 5 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 7 · 2018: 4 · 2017: 8 · 2016: 10 · 2015: 10 · 2014: 9 · 2013: 9 · 2012: 10
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- British Medical Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Gesundheit und Frauen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- prion disease, neuropathology, oxidative stress, neuronal apoptosis, dendritic cells, macrophages, pathogenesis
- MeSH terms
- Animals, Brain, Humans, Immunohistochemistry, Neurons, Prions, Species Specificity, Prion Diseases, Peripheral Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
